T-cell immunoglobulin and mucin-domain containing-3 in malignant cancers

被引:2
|
作者
Xu, Yun [1 ]
Jiang, Xiping [1 ]
Huang, Yaqing [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 3, Dept Gynecol, 185 Juqian St, Changzhou 213003, Peoples R China
关键词
T-cell immunoglobulin and mucin-domain containing-3 (Tim-3); human cancer; anti-Tim-3; antibody; cancer immunotherapy; 3 GENE POLYMORPHISMS; TIM-3; EXPRESSION; UP-REGULATION; THERAPEUTIC TARGET; POOR-PROGNOSIS; MELANOMA-CELLS; PD-1; DYSFUNCTION; ACTIVATION; EXHAUSTION;
D O I
10.21037/tcr.2017.05.08
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immune checkpoints are one of the key factors comprising the extensive network of the human immune system. Immune checkpoints ensure T-cell homeostasis, activation and differentiation. The checkpoint T-cell immunoglobulin and mucin-domain containing-3 (Tim-3) plays an important role in immune system. Tim-3 is a member of TIM family and can negatively regulate T helper 1 (Th1) immunity. A literature search for Tim-3 was performed via PubMed. It is suggested that the overexpression of Tim-3 is correlated with poorer prognosis for multiple cancers. Co-expression of Tim-3 and other immune checkpoints has been revealed. Blockade of Tim-3 exerts antitumor function and may have synergistic activity being alone or combined with anti-PD-1 antibody or chemotherapy. Thus, Tim-3 is a promising target for cancer immunotherapy.
引用
收藏
页码:613 / 619
页数:7
相关论文
共 50 条
  • [41] Role and function of T-cell immunoglobulin- and mucin domain-containing (TIM)-3 receptor on natural killer cells in solid tumors
    Tram Dao
    Matosevic, Sandro
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [42] T-Cell Immunoglobulin- and Mucin-Domain-Containing Molecule 3 Genetic Variants and HIV+ Non-Hodgkin Lymphomas
    Haihan Song
    Shaolin Ma
    Zhanshan Cha
    Lei Chen
    Danian Tong
    Lan Ma
    Weiguo Song
    Jianwen Bai
    Inflammation, 2013, 36 : 793 - 799
  • [43] The Role of T cell Immunoglobulin and Mucin Domain-3 in Immune Thrombocytopenia
    Zhang, X. -M.
    Shan, N. -N.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2014, 79 (04) : 231 - 236
  • [44] INVESTIGATING THE ROLE OF T-CELL IMMUNOGLOBULIN- AND MUCIN DOMAIN-CONTAINING (TIM)-3 ON NATURAL KILLER CELL METABOLISM AND CYTOTOXICITY AGAINST GLIOBLASTOMA MULTIFORME
    Dao, N.
    Matosevic, S.
    CYTOTHERAPY, 2022, 24 (05) : S127 - S127
  • [45] Investigating the Role of T-Cell Immunoglobulin- and Mucin Domain-Containing (TIM)-3 on Natural Killer Cell Metabolism and Cytotoxicity Against Glioblastoma Multiforme
    Ngoc Tram Dao
    MOLECULAR THERAPY, 2022, 30 (04) : 313 - 314
  • [46] Elevated Expression of T-Cell Immunoglobulin and Mucin Domain 3 on T Cells from Peripheral Blood in Patients with Cervical Carcinoma
    Li, Juan
    Sun, Xiao-fei
    Shen, Ying
    Yang, Qing
    Dai, Shu-yan
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2021, 86 (1-2) : 63 - 70
  • [47] Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain-Barre syndrome
    Liang, Song-lan
    Wang, Wei-zhi
    Huang, Shuo
    Wang, Xiao-kun
    Zhang, Suang
    Wu, Yun
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2012, 34 (06) : 1039 - 1046
  • [48] Association of TIM-1 (T-Cell Immunoglobulin and Mucin Domain 1) With Incidence of Stroke
    Song, Lu
    Sun, Jiangming
    Soderholm, Martin
    Melander, Olle
    Orho-Melander, Marju
    Nilsson, Jan
    Borne, Yan
    Engstromt, Gunnar
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (07) : 1777 - 1786
  • [49] Lineage-specific evolution of T-cell immunoglobulin and mucin domain 1 gene in the primates
    Hitoshi Ohtani
    Taeko K. Naruse
    Yuki Iwasaki
    Hirofumi Akari
    Takafumi Ishida
    Tetsuro Matano
    Akinori Kimura
    Immunogenetics, 2012, 64 : 669 - 678
  • [50] Immunological Role of Altered Expression of T-Cell Immunoglobulin- and Mucin Domain-Containing (TIM)-3 Receptor on Natural Killer Cells in Glioblastoma
    Ngoc Tram Dao
    MOLECULAR THERAPY, 2020, 28 (04) : 148 - 148